The manufacturers of the prescription medication Hytrin have agreed to pay a $30.7 million class action settlement. Abbott manufactures the name brand drug, while Geneva Pharmaceuticals manufactures its generic version, called Terazosin. The drugs are used to treat hypertension and enlarged prostate. According to the federal lawsuit, Abbott allegedly paid Geneva to delay introduction of its generic version and took other steps to delay competition from lower priced generic versions of its product. (Jun-06-05)
[MILWAUKEE BUSINESS JOURNAL]
[Settlement Information and Claim Form]
